Osteoprotegerin is known to be an inhibitory molecule for RANKL‐dependent osteoclast differentiation and function,51 and RANKL neutralization improved bone resorption in osteoporosis and rheumatoid arthritis.37, 38, 39. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.